cgp 39551 has been researched along with reserpine in 1 studies
Studies (cgp 39551) | Trials (cgp 39551) | Recent Studies (post-2010) (cgp 39551) | Studies (reserpine) | Trials (reserpine) | Recent Studies (post-2010) (reserpine) |
---|---|---|---|---|---|
75 | 0 | 4 | 15,546 | 223 | 436 |
Protein | Taxonomy | cgp 39551 (IC50) | reserpine (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 8.7875 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3.2092 | |
Quinolone resistance protein NorA | Staphylococcus aureus | 8.5429 | |
Mu-type opioid receptor | Homo sapiens (human) | 4.152 | |
Chromaffin granule amine transporter | Homo sapiens (human) | 0.05 | |
Synaptic vesicular amine transporter | Rattus norvegicus (Norway rat) | 0.0034 | |
Synaptic vesicular amine transporter | Homo sapiens (human) | 0.0147 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maj, J; Rogóz, Z; Skuza, G | 1 |
1 other study(ies) available for cgp 39551 and reserpine
Article | Year |
---|---|
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity.
Topics: 2-Amino-5-phosphonovalerate; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Biogenic Monoamines; Catalepsy; Central Nervous System Agents; Clonidine; Levodopa; Male; Methyltyrosines; Motor Activity; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reserpine; Tyrosine 3-Monooxygenase | 1993 |